Jessica Serra | Head of Investor Relations & ESG |
Mark Foley | Chief Executive Officer |
Dustin Sjuts | President |
Tobin Schilke | Chief Financial Officer & Principal Accounting Officer |
Seamus Fernandez | Guggenheim Partners |
Ken Cacciatore | Cowen |
Annabel Samimy | Stifel |
David Amsellem | Piper Sandler |
Tim Lugo | William Blair |
Douglas Tsao | H.C. Wainwright |
Serge Belanger | Needham & Company |
Welcome to the Revance Therapeutics Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, Tuesday, August 9, 2022. I would now like to turn the conference call over to Jessica Serra, Head of Investor Relations and ESG for Revance. Please go ahead.
Thank you, Bella.